The ERA-EDTA will consider abstracts related to unpublished clinical trials for a special “Late breaking clinical trials” session. The following trials will be considered for evaluation if they comply with the required characteristics:
– a prospective randomised intervention in renal patients (medication, education, dietetics, physiotherapy, etc…), including at least 100 patients;
– a prospective observational study, including at least 500 patients;
– approved by an institutional ethical committee;
– not previously reported or published.
Abstracts may be accepted as oral communications or posters, after being evaluated by the review committee.
The LBCT abstracts must be submitted through the congress website from March 2 to 27, 2020. Abstracts that do not meet the criteria above will not be considered for presentation.